What is the current Price Target for the Adverum Biotechnologies Inc stock?

The average Adverum Biotechnologies Inc target price is $5.10. This is 16.97% higher than the current stock price. The highest price target is 32.45%, the lowest is -7.34%. 7 Analysts have issued a price target Adverum Biotechnologies Inc 2026 .

How high will the Adverum Biotechnologies Inc stock rise?

No reliable answer can be given as to how high the Adverum Biotechnologies Inc stock will rise. The performance of stocks, including the Adverum Biotechnologies Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Adverum Biotechnologies Inc stock today?

The performance of Adverum Biotechnologies Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Adverum Biotechnologies Inc stock fall?

The decline in Adverum Biotechnologies Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Adverum Biotechnologies Inc Forecast, price target & analysts

$4.36

0.00% day before yesterday

Nasdaq, Dec 09, 03:30 pm CET

ISIN

US00773U1088

Symbol

ADVM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Adverum Biotechnologies Inc Target price 2025 - Analyst rating & recommendation

Adverum Biotechnologies Inc Classifications & Recommendation:

Buy

67%

Hold

33%

Adverum Biotechnologies Inc Price Target

Target Price	$5.10
Price	$4.36
Potential	16.97% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Adverum Biotechnologies Inc 2026 . The average Adverum Biotechnologies Inc target price is $5.10. This is 16.97% register free of charge higher than the current stock price. The highest price target is $5.78 32.45% register free of charge , the lowest is $4.04 7.34% register free of charge .
	A rating was issued by 12 analysts: 8 Analysts recommend Adverum Biotechnologies Inc to buy, 4 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Adverum Biotechnologies Inc stock has an average upside potential 2026 of 16.97% register free of charge . Most analysts recommend the Adverum Biotechnologies Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-6.62	-6.66
	43.03%	0.60%
P/E		negative
EV/Sales		5.43

8 Analysts have issued a Adverum Biotechnologies Inc forecast for earnings per share. The average Adverum Biotechnologies Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-6.62	43.03%
2025	$-6.66 0.60% Unlock
2026	$-3.67 44.89% Unlock
2027	$-3.12 14.99% Unlock
2028	$-3.87 24.04% Unlock
2029	$-4.52 16.80% Unlock
2030	$-4.62 2.21% Unlock
2031	$-2.52 45.45% Unlock
2032	$0.20 107.94% Unlock

Current	-1.16	7.05%
2025	-0.66 42.93% Unlock
2026	-1.19 80.30% Unlock
2027	-1.40 17.65% Unlock
2028	-1.13 19.29% Unlock
2029	-0.96 15.04% Unlock
2030	-0.94 2.08% Unlock
2031	-1.73 84.04% Unlock
2032	21.37 1,335.26% Unlock

Adverum Biotechnologies Inc...

Current Adverum Biotechnologies Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 17 2025
RBC Capital	Locked ➜ Locked	Locked	Oct 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 23 2025
Chardan Capital	Locked ➜ Locked	Locked	Aug 13 2025
Mizuho	Locked ➜ Locked	Locked	Jun 26 2025
Chardan Capital	Locked ➜ Locked	Locked	May 15 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 15 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 17 2025
Locked RBC Capital: Locked ➜ Locked	Oct 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 23 2025
Locked Chardan Capital: Locked ➜ Locked	Aug 13 2025
Locked Mizuho: Locked ➜ Locked	Jun 26 2025
Locked Chardan Capital: Locked ➜ Locked	May 15 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	May 15 2025

Discover more stocks with a high price target

Netflix 52.93%

BioNTech SE - ADR 49.16%

Coinbase Global, Inc. 48.32%

Adidas 46.93%

Deutsche Telekom 44.30%

Alibaba Group Holding Ltd 36.43%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now